Solesence, Inc.
SLSN Consumer Defensive Household & Personal Products
Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SLSN
Solesence, Inc. (SLSN) EV/Sales
As of 12 October 2026, Solesence, Inc. (SLSN) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 0.6× (April 2020) to 7.8× (December 2021); the current reading is higher than 49% of that period. That is above the Household & Personal Products industry median of 1.3× and above the Consumer Defensive sector median of 0.9×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.0× | (34.09%) |
| FY2024 | 3.1× | 197.18% |
| FY2023 | 1.0× | (36.94%) |
| FY2022 | 1.7× | (75.60%) |
| FY2021 | 6.8× | 239.41% |
| FY2020 | 2.0× | 133.69% |
| FY2019 | 0.9× | (50.76%) |
| FY2018 | 1.7× | 44.46% |
| FY2017 | 1.2× | (37.79%) |
| FY2016 | 1.9× | 89.37% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.4× | 3.55% |
| Mar 2026 | 1.3× | (34.97%) |
| Dec 2025 | 2.0× | (46.78%) |
| Sep 2025 | 3.8× | (21.28%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DSY Big Tree Cloud Holdings Limited compare | n/m |
| MLKMF Waldencast PLC compare | n/m |
| NUS Nu Skin Enterprises, Inc. compare | 0.2× |
| YSG Yatsen Holding Limited Sponsored ADR compare | 0.2× |
| GROV Grove Collaborative Holdings, Inc. compare | 0.2× |
| SKIN SkinHealth Systems Inc. compare | 0.7× |
| ACU Acme United Corporation. compare | 1.3× |
| SLSN Solesence, Inc. | 1.7× |
| UG United-Guardian, Inc. compare | 2.0× |
| Household & Personal Products industry median | 1.3× |
| Consumer Defensive sector median | 0.9× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)